[go: up one dir, main page]

BR9804993A - Composição antialérgica e antiinflamatória - Google Patents

Composição antialérgica e antiinflamatória

Info

Publication number
BR9804993A
BR9804993A BR9804993-3A BR9804993A BR9804993A BR 9804993 A BR9804993 A BR 9804993A BR 9804993 A BR9804993 A BR 9804993A BR 9804993 A BR9804993 A BR 9804993A
Authority
BR
Brazil
Prior art keywords
composition
antiallergic
inflammatory composition
allergic
antinflamatory
Prior art date
Application number
BR9804993-3A
Other languages
English (en)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to BR9804993-3A priority Critical patent/BR9804993A/pt
Priority to CNB981223176A priority patent/CN100350908C/zh
Priority to EP98660134A priority patent/EP1005865B1/en
Publication of BR9804993A publication Critical patent/BR9804993A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: <B> "COMPOSIçãO ANTIALéRGICA E ANTINFLAMATóRIA"<D>. é revelada uma nova composição de Nimesulida e sais da mesma e Cetirizina possuindo ação antileucotriênica, anti-histamínica, anti-alérgica e antiinflamatória. A composição é útil na cura de distúrbios alérgicos tais como rinite, bronquite, asma, urticária e semelhantes.
BR9804993-3A 1998-11-10 1998-11-10 Composição antialérgica e antiinflamatória BR9804993A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR9804993-3A BR9804993A (pt) 1998-11-10 1998-11-10 Composição antialérgica e antiinflamatória
CNB981223176A CN100350908C (zh) 1998-11-10 1998-11-13 新颖的抗变态反应抗炎组合物
EP98660134A EP1005865B1 (en) 1998-11-10 1998-12-04 A anti-allergy anti-inflammatory composition comprising nimesulide and cetirizine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR9804993-3A BR9804993A (pt) 1998-11-10 1998-11-10 Composição antialérgica e antiinflamatória
CNB981223176A CN100350908C (zh) 1998-11-10 1998-11-13 新颖的抗变态反应抗炎组合物
EP98660134A EP1005865B1 (en) 1998-11-10 1998-12-04 A anti-allergy anti-inflammatory composition comprising nimesulide and cetirizine

Publications (1)

Publication Number Publication Date
BR9804993A true BR9804993A (pt) 2000-06-06

Family

ID=27160183

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804993-3A BR9804993A (pt) 1998-11-10 1998-11-10 Composição antialérgica e antiinflamatória

Country Status (3)

Country Link
EP (1) EP1005865B1 (pt)
CN (1) CN100350908C (pt)
BR (1) BR9804993A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80667C2 (en) * 1999-09-28 2007-10-25 Panacea Biotec Ltd Controlled release composition comprising nimesulide and process for the preparation thereof
EP1147767A1 (en) * 2000-04-22 2001-10-24 J.B. Chemicals &amp; Pharmaceuticals Ltd. Controlled release formulations of nimesulide and a process for the manufacture thereof
IN190963B (pt) * 2000-06-20 2003-09-06 Ajanta Pharma Ltd
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
GB0115181D0 (en) * 2001-06-20 2001-08-15 Glaxo Group Ltd Novel use
EP1327463A1 (de) * 2002-01-04 2003-07-16 Oramon Arzneimittel GmbH Gel enthaltend Cetirizin und Loratadin zur topischen Anwendung
JP2003212773A (ja) 2002-01-04 2003-07-30 Oramon Arzneimittel Gmbh セチリジン及びロラタジンの局所医薬組成物
TWI347845B (en) 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AR066016A1 (es) * 2007-04-11 2009-07-15 Alcon Res Ltd Uso de un inhibidor del tnf alfa junto con una antihistamina para tratar la rinitis alergica y la conjuntivitis alergica
US20090304826A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for dermatoses
WO2010038240A1 (en) * 2008-09-30 2010-04-08 Panacea Biotec Limited Pharmaceutical composition comprising nimesulide and levocetirizine
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
DE102013000068A1 (de) 2013-01-08 2014-07-10 Audi Ag Verfahren zum Synchronisieren von Anzeigeeinrichtungen eines Kraftfahrzeugs
WO2022094422A1 (en) * 2020-10-30 2022-05-05 The Board Of Trustees Of The Leland Stanford Junior University Drugs targeting inflammation for the treatment of osteoarthritis and other inflammatory diseases
EP4479048A1 (en) 2022-02-17 2024-12-25 Faes Farma, S.A. Bilastine composition for once-daily parenteral administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use

Also Published As

Publication number Publication date
EP1005865A1 (en) 2000-06-07
EP1005865B1 (en) 2003-11-19
CN100350908C (zh) 2007-11-28
CN1253776A (zh) 2000-05-24

Similar Documents

Publication Publication Date Title
BR9804993A (pt) Composição antialérgica e antiinflamatória
BR9812699A (pt) Derivados de benzamidina
BRPI0014076B8 (pt) benzamidas e inibidores correlatos do fator xa
DK1254899T3 (da) Piperazinderivater og deres anvendelse som anti-inflammatoriske midler
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
BR9814118A (pt) Nova composição de matéria
YU7797A (sh) Kombinovana terapija za osteoporozu
WO2002040544A3 (en) Mutant human factor ix with an increased resistance to inhibition by heparin
BR9712652A (pt) Tienopirimidinas possuindo ação inibidora de pde v.
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
ATE359271T1 (de) Phenylderivate
BR9610277A (pt) Derivados de piperazino como antagonistas de neurowuinina
ATE413388T1 (de) Muskarin antagonisten
BR0011778A (pt) Tienopirimidinas
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
ES2154318T3 (es) Agentes antitromboticos.
BRPI0107493B8 (pt) substâncias para uso no tratamento de psoríase
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
BR9808302A (pt) O uso de levobupivacaìna na cirurgia pediátrica
BR0307714A (pt) Benzoilamidas substituìdas com azabiciclo e tioamidas para tratamento de distúrbios relacionados ao cns
NO975028D0 (no) Piperazinoderivater som neurokininantagonister
BR0008608A (pt) Derivados de pirazol-3-ona
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
BR9910021A (pt) Derivados de bifenila
BR9712720A (pt) Derivados de piperazina como antagÈnicos de neurocinina

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B09B Decision: refusal

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE INFRINGE O ARTIGO 25 DA LEI 9279/96

B12B Appeal: appeal against refusal
B07E Notice of approval relating to section 229 industrial property law
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time